These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 3916744
1. Adjuvant systemic therapy of breast cancer. Lippman ME. Important Adv Oncol; 1985; ():254-72. PubMed ID: 3916744 [No Abstract] [Full Text] [Related]
2. [Adjuvant chemotherapy in operable breast cancer]. Senn HJ. Dtsch Med Wochenschr; 1984 Jun 29; 109(26):1034-43. PubMed ID: 6734462 [No Abstract] [Full Text] [Related]
3. Systemic therapy in resectable breast cancer. Bonadonna G, Valagussa P. Hematol Oncol Clin North Am; 1989 Dec 29; 3(4):727-42. PubMed ID: 2691496 [Abstract] [Full Text] [Related]
4. Adjuvant systemic therapy in primary breast cancer. Mouridsen HT, Palshof T. Acta Chir Scand Suppl; 1984 Dec 29; 519():43-53. PubMed ID: 6393664 [No Abstract] [Full Text] [Related]
5. Adjuvant systemic therapy for early breast cancer: progress and controversies. Hortobagyi GN. Clin Cancer Res; 2001 Jul 29; 7(7):1839-42. PubMed ID: 11448893 [No Abstract] [Full Text] [Related]
6. Adjuvant chemotherapy of early breast cancer. Med Lett Drugs Ther; 1990 May 18; 32(818):49-50. PubMed ID: 2333039 [No Abstract] [Full Text] [Related]
9. Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer. Donegan WL. Can J Surg; 1992 Aug 18; 35(4):371-7. PubMed ID: 1498737 [Abstract] [Full Text] [Related]
11. [Adjuvant therapy of breast carcinoma]. Kaufmann M. Dtsch Med Wochenschr; 1994 Mar 18; 119(11):387-91. PubMed ID: 8131718 [No Abstract] [Full Text] [Related]
12. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. Taghian A, Jeong JH, Mamounas E, Anderson S, Bryant J, Deutsch M, Wolmark N. J Clin Oncol; 2004 Nov 01; 22(21):4247-54. PubMed ID: 15452182 [Abstract] [Full Text] [Related]
13. Weekly epirubicin plus tamoxifen versus tamoxifen alone as adjuvant treatment of operable, node-positive, elderly breast cancer patients. Alliot C. J Clin Oncol; 2005 Jun 20; 23(18):4237-8; author reply 4238-9. PubMed ID: 15961776 [No Abstract] [Full Text] [Related]
14. [Adjuvant therapy also in node-negative breast cancer?]. Barth JA. Zentralbl Gynakol; 1990 Jun 20; 112(2):57-9. PubMed ID: 2316296 [No Abstract] [Full Text] [Related]
15. Current strategies in operable breast cancer. Deckers PJ. Hosp Pract (Off Ed); 1987 Jan 30; 22(1A):41-9, 53-4, 59-68. PubMed ID: 3100553 [No Abstract] [Full Text] [Related]
16. [A randomized controlled study comparing uracil-tegafur (UFT)+tamoxifen (UFT+TAM therapy) with cyclophosphamide+adriamycin+5-fluorouracil (CAF therapy) for women with stage I , II, or IIIa breast cancer with four or more involved nodes in the adjuvant setting]. Inaji H, Sakai K, Oka T, Ozawa K, Saito Y, Senoo T, Taguchi T, Terasawa T, Nakao K, Mori T, Koyama H, Oshima A. Gan To Kagaku Ryoho; 2006 Oct 30; 33(10):1423-9. PubMed ID: 17033231 [Abstract] [Full Text] [Related]
18. [Early-stage breast cancer - strategies for adjuvant systemic therapy]. Görner M, Just M, Gerull S. Handchir Mikrochir Plast Chir; 2008 Aug 30; 40(4):230-8. PubMed ID: 18716990 [Abstract] [Full Text] [Related]